Imunon, Inc. (IMNN)
Data as of , from SEC Form 4 filings.
See up to 3 months of IMNN. The 7-day demo opens the 1M and 3M ranges and puts IMNN on your watchlist.
Start 7-day demoLatest IMNN insider trades
Susan Eylward - OfficerOpen-market sale$4K- Susan Eylward - OfficerOpen-market sale$4K
About Imunon, Inc. (IMNN)
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
- LAWRENCEVILLE, NJ
- 20
- 1995
- XNAS
IMNN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 9,665 | $16K |
| Grant or award | 29 | 145,174 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
IMNN insider transactions (Form 4)
3659 Form 4 filings on record, the earliest from Oct 8, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Susan Eylward - Officer | Open-market sale | Common Stock | 920 | $1.88 | $2K | |
| Susan Eylward - Officer | Grant or award | Common Stock | 920 footnote F1 | $1.91 | $2K | |
| ||||||
| Douglas Vincent Faller - Officer | Grant or award | Common Stock | 1,308 footnote F1 | $1.91 | $2K | |
| ||||||
| Stacy Lindborg - Officer | Grant or award | Common Stock | 2,534 footnote F1 | $1.91 | $5K | |
| ||||||
| Douglas Vincent Faller - Officer | Grant or award | Common Stock | 21,896 footnote F1 | $1.72 | $38K | |
| ||||||
| Susan Eylward - Officer | Open-market sale | Common Stock | 11,800 | $1.75 footnote F2 | $21K | |
| Susan Eylward - Officer | Grant or award | Common Stock | 14,696 footnote F1 | $1.72 | $25K | |
| ||||||
 Michael H. Tardugno - Officer | Grant or award | Common Stock | 42,519 footnote F1 | $1.72 | $73K | |
| ||||||
| Stacy Lindborg - Officer | Grant or award | Common Stock | 67,150 footnote F1 | $1.72 | $115K | |
| ||||||
| Michael H. Tardugno - Officer | Grant or award | Common Stock | 4,629 footnote F1 | $1.82 | $8K | |
| ||||||
| Stacy Lindborg - Officer | Grant or award | Common Stock | 1,803 footnote F1 | $1.82 | $3K | |
| ||||||
| Michael H. Tardugno - Officer | Grant or award | Common Stock | 4,089 footnote F1 | $2.06 | $8K | |
| ||||||
| Stacy Lindborg - Officer | Grant or award | Common Stock | 1,593 footnote F1 | $2.06 | $3K | |
| ||||||
| Michael H. Tardugno - Officer | Grant or award | Common Stock | 3,484 footnote F1 | $2.20 | $8K | |
| ||||||
 Christine A. Pellizzari - Director | Grant or award | Common Stock | 5,557 footnote F1 | $2.20 | $12K | |
| ||||||
 James E. Dentzer - Director | Grant or award | Common Stock | 11,148 footnote F1 | $2.20 | $25K | |
| ||||||
| Donald P. Braun - Director | Grant or award | Common Stock | 5,011 footnote F1 | $2.20 | $11K | |
| ||||||
| Frederick J. Fritz - Director | Grant or award | Common Stock | 10,330 footnote F1 | $2.20 | $23K | |
| ||||||
| Stacy Lindborg - Officer | Grant or award | Common Stock | 1,491 footnote F1 | $2.20 | $3K | |
| ||||||
| Stacy Lindborg - Officer | Option exercise | Common Stock | 1,667 | $0.00 | - | |
| Stacy Lindborg - Officer | Option exercise | Restricted Stock | 1,667 | $0.00 | - | |
| Susan Eylward - Officer | Grant or award | Stock Option (Right to Buy) | 417 | $0.00 | - | |
| Kimberly Bragg - Officer | Grant or award | Stock Option (Right to Buy) | 667 | $0.00 | - | |
| Stacy Lindborg - Officer | Grant or award | Stock Option (Right to Buy) | 5,000 | $0.00 | - | |
| Donald P. Braun - Director | Grant or award | Common Stock | 2,040 | $8.00 | $19K | |
| Donald P. Braun - Director | Grant or award | Stock Option (Right to Buy) | 250 | $0.00 | - | |
| Khursheed Anwer - Officer | Grant or award | Stock Option (Right to Buy) | 1,667 | $0.00 | - | |
| Frederick J. Fritz - Director | Grant or award | Common Stock | 3,161 | $8.00 | $29K | |
| Frederick J. Fritz - Director | Grant or award | Stock Option (Right to Buy) | 250 | $0.00 | - | |
| James E. Dentzer - Director | Grant or award | Common Stock | 3,318 | $8.00 | $31K | |
| James E. Dentzer - Director | Grant or award | Stock Option (Right to Buy) | 250 | $0.00 | - | |
| Michael H. Tardugno - Officer | Grant or award | Stock Option (Right to Buy) | 1,667 | $0.00 | - | |
| Christine A. Pellizzari - Director | Grant or award | Common Stock | 2,248 | $8.00 | $21K | |
| Christine A. Pellizzari - Director | Grant or award | Stock Option (Right to Buy) | 250 | $0.00 | - | |
| Michael H. Tardugno - Officer | Grant or award | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| Susan Eylward - Officer | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
IMNN insider trading FAQ
What is the latest insider trade for IMNN?
Imunon, Inc. (IMNN) had 29 insider filings in the last 90 days, with the most recent on 2026-10-13. The full record for IMNN runs to 59 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IMNN stock?
No insider purchases of IMNN were filed in the last 90 days.
How many insiders are selling IMNN stock?
4 insider sales of IMNN were filed in the last 90 days, totaling $16K.
Where can I see IMNN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IMNN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Michael H. Tardugno view on EDGAR
- - Stacy Lindborg view on EDGAR
- - Douglas Vincent Faller view on EDGAR
- - Michael H. Tardugno view on EDGAR
- - Stacy Lindborg view on EDGAR
- - Douglas Vincent Faller view on EDGAR
- - Michael H. Tardugno view on EDGAR
- - Stacy Lindborg view on EDGAR
- - Douglas Vincent Faller view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Insider activity in Health Care
- Where IMNN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IMNN with a 7-day demo
- IMNN on your watchlist
- Every IMNN Form 4 filing on record
- Up to 3 months of IMNN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
